BAX · Baxter International Inc.
$22.042026-07-21Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$0
-113.6% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($-3 · $-7) Analysts Range ($17 · $27) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $10.4B | — | 6.8% | 45.0% | $389MM | $469MM | $858MM | 8.8% | — | 2.1% | $18.9B | $5.16 | — |
| 2024.Q4 | $10.4B | 0.0% | 6.8% | 0.0% | $798MM | $504MM | $1.3B | 17.4% | — | 4.3% | $18.4B | $5.16 | — |
| 2025.Q1 | $10.6B | 2.7% | 0.1% | 20.7% | $11MM | $337MM | $348MM | 11.1% | — | 0.1% | $14.9B | $-1.26 | — |
| 2025.Q4 | $10.6B | 0.0% | 0.1% | 0.0% | $25MM | $351MM | $376MM | 17.3% | — | 0.2% | $13.7B | $-1.26 | — |
| 2026.Q1 | $11.3B | 6.4% | -2.7% | 0.0% | −$579MM | $569MM | −$10MM | 11.9% | — | -4.3% | $13.5B | $-2.13 | — |
| italics below = DCF projection · 10yr Rev CAGR: 3.4% |
| 2027.Q1 | $11.4B | +0.8% | -2.2% | 2.0% | −$243MM | −$114MM | −$357MM | 13.0% | −$316MM | -1.8% | $13.6B | $-0.47 | — |
| 2028.Q1 | $11.7B | +2.1% | -2.2% | 4.0% | −$251MM | −$308MM | −$559MM | 12.6% | −$439MM | -1.8% | $13.9B | $-0.49 | — |
| 2029.Q1 | $12.0B | +3.4% | -2.2% | 6.0% | −$254MM | −$522MM | −$776MM | 12.2% | −$543MM | -1.8% | $14.4B | $-0.49 | — |
| 2030.Q1 | $12.5B | +3.8% | -2.2% | 8.0% | −$258MM | −$626MM | −$884MM | 11.7% | −$554MM | -1.8% | $15.1B | $-0.50 | — |
| 2031.Q1 | $13.0B | +3.9% | -2.2% | 10.0% | −$262MM | −$703MM | −$965MM | 11.3% | −$544MM | -1.7% | $15.8B | $-0.51 | — |
|
| Term. Yr+ | $16.5B | 4.1% | 17.8% | 20.0% | $2.3B | −$1.1B | $1.3B | 8.6% | $9.8B | 8.9% | — | — | — |
Active scenario IV: $0 (-113.6% vs market)